Sutro Biopharma Inc
NASDAQ:STRO
Sutro Biopharma Inc
NASDAQ:STRO
Kurs:
25,1
USD
3,85%
Markt geschlossen
Marktkap.:
$415,91 Mio.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
Sutro Biopharma Inc
NASDAQ:STRO
|
US |
|
Kokusai Electric Corp
OTC:KOKSF
|
JP |
|
T
|
Telkom Indonesia (Persero) Tbk PT
SWB:TCID
|
ID |
|
Nanobiotix SA
F:5NRA
|
FR |
|
W
|
Warner Bros Discovery Inc
XHAN:J5A
|
US |
|
B
|
Boeing Co
XHAN:BCO
|
US |
Cashflow-Rechnung
Cashflow-Rechnung
Sutro Biopharma Inc
Sutro Biopharma Inc
Währung: USD
| Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | Mar-2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operativer Cashflow | ||||||||||||||||||||||||||||||||||
| Nettogewinn |
(32)
|
(40)
|
(49)
|
(35)
|
(38)
|
(40)
|
(42)
|
(56)
|
(61)
|
(17)
|
13
|
(32)
|
(43)
|
(79)
|
(127)
|
(106)
|
(114)
|
(134)
|
(123)
|
(119)
|
(130)
|
(143)
|
(172)
|
(107)
|
(115)
|
(124)
|
(124)
|
(227)
|
(245)
|
(209)
|
(217)
|
(191)
|
(154)
|
|
| Abschreibungen |
6
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
6
|
6
|
6
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
7
|
8
|
7
|
7
|
|
| Aktienbasierte Vergütung |
2
|
2
|
2
|
3
|
5
|
7
|
10
|
10
|
11
|
11
|
12
|
12
|
13
|
16
|
19
|
23
|
26
|
27
|
27
|
26
|
25
|
25
|
25
|
25
|
25
|
24
|
25
|
25
|
23
|
22
|
18
|
14
|
11
|
|
| Sonstige nicht zahlungswirksame Posten |
5
|
3
|
3
|
1
|
2
|
5
|
7
|
9
|
10
|
(35)
|
(63)
|
(28)
|
(16)
|
30
|
62
|
37
|
29
|
38
|
35
|
13
|
17
|
3
|
10
|
23
|
19
|
29
|
8
|
20
|
27
|
35
|
58
|
57
|
53
|
|
| Gezahlte Steuern |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
15
|
15
|
18
|
18
|
3
|
3
|
0
|
0
|
|
| Gezahlte Zinsen |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Veränderung des Working Capital |
(31)
|
(3)
|
55
|
43
|
38
|
36
|
(27)
|
(23)
|
(17)
|
(12)
|
(16)
|
(11)
|
(25)
|
(28)
|
(19)
|
(18)
|
(6)
|
7
|
88
|
104
|
85
|
83
|
7
|
(34)
|
(27)
|
14
|
3
|
9
|
16
|
(83)
|
(71)
|
(50)
|
(58)
|
|
| Cashflow aus operativer Tätigkeit |
(52)
N/A
|
(36)
+31%
|
14
N/A
|
13
-8%
|
8
-41%
|
6
-22%
|
(58)
N/A
|
(65)
-12%
|
(64)
+2%
|
(61)
+5%
|
(62)
-3%
|
(68)
-9%
|
(80)
-17%
|
(72)
+9%
|
(79)
-9%
|
(82)
-3%
|
(87)
-6%
|
(84)
+2%
|
6
N/A
|
4
-39%
|
(22)
N/A
|
(50)
-126%
|
(150)
-198%
|
(112)
+25%
|
(115)
-3%
|
(74)
+35%
|
(106)
-42%
|
(192)
-81%
|
(195)
-2%
|
(250)
-28%
|
(223)
+11%
|
(177)
+20%
|
(152)
+14%
|
|
| Investitions-Cashflow | ||||||||||||||||||||||||||||||||||
| Investitionsausgaben |
(4)
|
(2)
|
(1)
|
(2)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(8)
|
(7)
|
(9)
|
(12)
|
(14)
|
(15)
|
(14)
|
(11)
|
(7)
|
(8)
|
(7)
|
(7)
|
(6)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(4)
|
(3)
|
(3)
|
(2)
|
(1)
|
|
| Sonstige Posten |
36
|
9
|
(79)
|
(79)
|
(156)
|
(147)
|
(55)
|
(48)
|
73
|
8
|
0
|
8
|
(154)
|
(87)
|
(88)
|
(82)
|
72
|
111
|
31
|
(27)
|
7
|
24
|
(12)
|
0
|
(3)
|
(151)
|
111
|
222
|
142
|
225
|
117
|
47
|
17
|
|
| Cashflow aus Investitionstätigkeit |
32
N/A
|
7
-77%
|
(81)
N/A
|
(80)
+0%
|
(158)
-97%
|
(149)
+6%
|
(57)
+62%
|
(51)
+10%
|
69
N/A
|
2
-97%
|
(7)
N/A
|
1
N/A
|
(163)
N/A
|
(100)
+39%
|
(102)
-3%
|
(97)
+5%
|
57
N/A
|
99
+73%
|
24
-76%
|
(35)
N/A
|
(1)
+98%
|
18
N/A
|
(18)
N/A
|
(4)
+79%
|
(7)
-85%
|
(154)
-2.012%
|
107
N/A
|
219
+103%
|
139
-37%
|
221
+60%
|
114
-48%
|
45
-61%
|
16
-64%
|
|
| Finanzierungs-Cashflow | ||||||||||||||||||||||||||||||||||
| Nettoausgabe von Stammaktien |
15
|
48
|
85
|
170
|
170
|
136
|
85
|
0
|
1
|
92
|
110
|
255
|
256
|
165
|
149
|
2
|
1
|
10
|
42
|
58
|
69
|
62
|
30
|
12
|
1
|
97
|
97
|
99
|
98
|
1
|
0
|
0
|
103
|
|
| Nettoaufnahme von Schulden |
0
|
0
|
0
|
0
|
(1)
|
(2)
|
(4)
|
(5)
|
11
|
12
|
14
|
15
|
0
|
0
|
0
|
0
|
0
|
(3)
|
(6)
|
(9)
|
(13)
|
(13)
|
(13)
|
(13)
|
(13)
|
(10)
|
(7)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
|
| Sonstiges |
(1)
|
(1)
|
(2)
|
1
|
1
|
2
|
4
|
1
|
0
|
0
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
1
|
1
|
1
|
1
|
(0)
|
(0)
|
139
|
136
|
138
|
138
|
(2)
|
2
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cashflow aus Finanzierungstätigkeit |
15
N/A
|
47
+224%
|
83
+75%
|
171
+106%
|
170
0%
|
137
-20%
|
85
-38%
|
(4)
N/A
|
12
N/A
|
104
+770%
|
123
+18%
|
269
+120%
|
255
-5%
|
164
-36%
|
148
-10%
|
3
-98%
|
2
-33%
|
8
+253%
|
37
+374%
|
48
+32%
|
56
+17%
|
188
+235%
|
153
-19%
|
138
-10%
|
125
-9%
|
84
-33%
|
91
+8%
|
94
+3%
|
97
+4%
|
1
-99%
|
0
-89%
|
0
-59%
|
103
+234.111%
|
|
| Veränderung der Zahlungsmittel | ||||||||||||||||||||||||||||||||||
| Nettoveränderung der Zahlungsmittel |
(5)
N/A
|
19
N/A
|
16
-16%
|
103
+548%
|
20
-81%
|
(6)
N/A
|
(29)
-387%
|
(120)
-309%
|
17
N/A
|
46
+171%
|
53
+16%
|
202
+279%
|
13
-94%
|
(8)
N/A
|
(34)
-316%
|
(176)
-422%
|
(27)
+85%
|
23
N/A
|
66
+191%
|
17
-75%
|
34
+99%
|
156
+364%
|
(15)
N/A
|
22
N/A
|
3
-88%
|
(144)
N/A
|
92
N/A
|
121
+31%
|
41
-66%
|
(27)
N/A
|
(108)
-297%
|
(132)
-22%
|
(33)
+75%
|
|
| Free Cashflow | ||||||||||||||||||||||||||||||||||
| Free Cashflow |
(56)
N/A
|
(38)
+32%
|
12
N/A
|
11
-10%
|
6
-46%
|
4
-35%
|
(60)
N/A
|
(69)
-14%
|
(68)
+1%
|
(66)
+3%
|
(70)
-6%
|
(75)
-8%
|
(88)
-18%
|
(85)
+4%
|
(93)
-10%
|
(97)
-4%
|
(101)
-4%
|
(96)
+5%
|
(1)
+99%
|
(4)
-262%
|
(29)
-583%
|
(57)
-93%
|
(156)
-174%
|
(116)
+26%
|
(119)
-3%
|
(77)
+35%
|
(109)
-41%
|
(195)
-78%
|
(199)
-2%
|
(253)
-27%
|
(225)
+11%
|
(179)
+21%
|
(152)
+15%
|
|
Wechseln zu:
Wechseln zu:
Weiter STRO recherchieren
Other Sutro Biopharma Inc listings:
Mehr entdecken
